
High-income countries gained the most economic value from COVID-19 vaccines but low-income countries got the most per-person vaccinations relative to GDP.
A selection of the latest COVID-19 vaccine research out of IDWeek 2022.
COVID-19 remained top of mind at IDWeek 2022, with dozens of posters, oral abstracts, and symposia presenting new research on the topic. Click through the slideshow to read a selection of the latest research on COVID-19 vaccines and follow along with Drug Topics® continuing coverage of IDWeek 2022.
References






